Your session is about to expire
← Back to Search
Peezy Device for Asymptomatic Bacteriuria (Peezy-DAB Trial)
Peezy-DAB Trial Summary
This trial will compare rates of contaminants in urine collected using a standard method versus the PEEZY device, specifically among pregnant women with different BMI levels.
Peezy-DAB Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Peezy-DAB Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had multiple urinary tract infections in the past.You are currently taking antibiotics and need to continue taking them.You have abnormalities in your urinary tract.
- Group 1: Clean catch BMI < 30
- Group 2: Clean catch BMI > 30
- Group 3: PEEZy collection BMI < 30
- Group 4: PEEZY collection BMI > 30
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Out of how many applicants will this research select participants?
"That is correct, the information available on clinicaltrials.gov supports that this research is actively looking for volunteers. The study was originally posted on August 1st, 2022 and was last updated September 21st, 2022. They are aiming to have 200 people participate from 1 location."
Has the FDA cleared PEEZY for use with patients who have a BMI above 30?
"PEEZY collection BMI > 30 is estimated to be a 3 on the Power Safety Scale because it is a Phase 3 trial."
Are there any empty slots in this trial for new participants?
"This study is looking for candidates according to the clinicaltrials.gov website. The study was first posted on 8/1/2022 and was last updated on 9/21/2022."
Share this study with friends
Copy Link
Messenger